SCHEMBL4848146

SCHEMBL4848146

Cc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2ccc(O)c(CN(C)C)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.44
ACHE P22303 3/20 0.42
BCHE P06276 2/20 0.42
TUBB4A P04350 3/20 0.42
TUBB P07437 3/20 0.42
TUBA3C P0DPH7 3/20 0.42
TUBA1B P68363 3/20 0.42
TUBA4A P68366 3/20 0.42
TUBB4B P68371 3/20 0.42
TUBB3 Q13509 3/20 0.42
TUBB2A Q13885 3/20 0.42
TUBB8 Q3ZCM7 3/20 0.42
TUBA3E Q6PEY2 3/20 0.42
TUBA1A Q71U36 3/20 0.42
TUBA1C Q9BQE3 3/20 0.42
TUBB6 Q9BUF5 3/20 0.42
TUBB2B Q9BVA1 3/20 0.42
TUBB1 Q9H4B7 3/20 0.42
MCL1 Q07820 1/20 0.40
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849675 1.00 SLC6A9 (0.44) SLC6A9ACHEBCHETUBB4ATUBB
SCHEMBL4852790 0.93 BCHE (0.49) SLC6A9ACHEBCHETUBB4ATUBB
SCHEMBL4857422 0.93 BCHE (0.49) SLC6A9ACHEBCHETUBB4ATUBB
SCHEMBL4851256 0.88 SLC6A9 (0.46) SLC6A9ACHEBCHEHDAC3HDAC6
SCHEMBL4856617 0.88 SLC6A9 (0.46) SLC6A9ACHEBCHEHDAC3HDAC6
SCHEMBL4854959 0.87 SLC6A9 (0.47) SLC6A9ACHEBCHETUBB4ATUBB
SCHEMBL4856397 0.87 SLC6A9 (0.47) SLC6A9ACHEBCHETUBB4ATUBB
SCHEMBL4847435 0.86 SLC6A9 (0.46) SLC6A9ACHEBCHEMCL1
SCHEMBL4849440 0.86 SYK (0.41) ACHEBCHEMAOBMAOA
SCHEMBL4847107 0.86 SYK (0.41) ACHEBCHEMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed